Content area

|
|

Evidensen for behandling med medicinsk cannabis til patienter med bipolar affektiv sindslidelse er begrænset

Forfatter(e)
Marco Payer Blach Bentzen & Maj Vinberg Psykiatrisk Center København, Rigshospitalet

Ugeskr Læger 2018;180:V01180046
Reference: 
Ugeskr Læger 2018;180:V01180046
Blad nummer: 

Marco Payer Blach Bentzen & Maj Vinberg:

Limited evidence for therapy with medical cannabis in patients with bipolar disorder

Ugeskr Læger 2018;180:V01180046

There is an increased interest among patients with bipolar disorder for using medical cannabis. The aim of this review was to elucidate, whether medical cannabis has a potential role in the treatment of bipolar disorder. Only one study with two case reports has been conducted. The two manic patients showed no improvement during the treatment but tolerated cannabis, and no side effects were reported. Overall, there is a lack of evidence for the use of cannabis in bipolar disorder. Future randomised clinical trials are warranted.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Pedram Kazemi-Esfarjani | 18/01
2 kommentarer
af Johan Ludvig Reventlow | 18/01
1 Kommentar
af Claus Manniche | 18/01
1 Kommentar
af Bjarne Skjødt Hjaltalin | 18/01
1 Kommentar
af Yngve Lund | 17/01
13 kommentarer
af Jens Meyer Svendsen | 16/01
1 Kommentar
af Claus Rasmussen | 16/01
3 kommentarer
af Thomas Eric Olesen | 15/01
2 kommentarer